Learn about our safety approach to COVID-19 >

globe icon Global

Be a Game-Changer in Cellular Therapy

We’re leading the way in Chimeric Antigen Receptor T-Cell therapy (CAR T). You can too. This emerging immunotherapy reprograms a patient’s own CD4+ and CD8+ T cells to recognize and attack cancer. Now, we’re exploring even more possibilities through a number of clinical trials. And as we continue to expand, we’re looking for quality-focused, passionate people to help us dive deeper and go further. Bring your love of innovation and desire to make an impact to this exciting field today.

Learn More


New State-of-the-Art Facility

Construction is underway for a new cell therapy manufacturing facility in Devens, MA. This is a part of Bristol Myers Squibb’s significant investment to support clinical and commercial manufacturing of transformative cell therapies for patients with aggressive hematological cancers. The Devens site will be equipped to enable quick ramp up of capacity for clinical and commercial cell therapy products. Manufacturing cell therapies is both operationally and technically complex because they are manufactured uniquely for each individual patient, and it is critical for companies to develop a reliable, quality supply and rapid turnaround time.

View Cellular Therapy Jobs in Devens

Newest Jobs

From Manufacturing Managers to Principal Scientists, explore how you can find your unique spot on our cellular therapy team today.

View Cellular Therapy Jobs

Innovation Through Collaboration

As we continue to expand our footprint in cellular therapy, hear how our team’s unique perspectives contribute to the larger mission of helping patients.